John A. Cuenca, MD

🇪🇨 IM PGY-3 Chief Resident @TigmerSA_IntMed @UnivHealthSA| Upcoming CCM fellow @BCMHouston| Former researcher @MDAndersonNews & @ONCCCRNET

[John A. Cuenca, MD @JohnCuencaMD]

Incredibly humbled to match into Critical Care Medicine at @bcmhouston

A dream since medical school, shaped by my family and mentors who believed in me.

Grateful for every step of this journey. Ready for what comes next.

#Match2025 @TheNRMP @SCCM @accpchest

[Tommaso Scquizzato, MD @tscquizzato]

5 studies from #ISICEM26 every intensivist should know 👇

🧬 Immune dysregulation in pneumonia & sepsis
💨 High-flow vs standard oxygen
🫁 ARF in immunocompromised patients
🩸 Prehospital whole blood in trauma
🏥 ICU restraint strategies

@ISICEM

[John A. Cuenca, MD @JohnCuencaMD]

@AlbertoCalleMd @StoCANcer What an inspiring story, Alberto. Thank you for sharing such courage and resilience. Your patients will be incredibly lucky to have you as their anesthesiologist. God bless you.

[Sheila Myatra @SheilaMyatra]

The "current standard of care for septic shock" just published in ICM is an evidence based update. Current optimal management for septic shock involves prompt recognition, judicious use of fluids & vasoactive drugs, early appropriate antibiotic use, regular reassessment & more..

[NEJM @NEJM]

Presented at CCR Down Under 2025:

In a randomized trial involving critically ill patients undergoing intubation in EDs or ICUs, the use of ketamine for the induction of anesthesia did not lead to significantly lower in-hospital mortality than etomidate. Full trial results: https://t.co/ovSy71Gi1j

@CritCareReviews

[Sheila Myatra @SheilaMyatra]

Positive communication in ICU reduces burnout and enhances workplace culture among staff. Read the HELLO trial, just published in ICM https://t.co/8wNkY9jyX2 @ElieAzoulay5

[NEJM @NEJM]

Original Article: A Pragmatic Trial of Glucocorticoids for Community-Acquired Pneumonia https://t.co/WEQvqhbqKY

Editorial: Glucocorticoids for Pneumonia in Africa — Old Therapy, New Context https://t.co/6HbKy8HGeF

#LIVES2025

[JAMA @JAMA_current]

The Sequential Organ Failure Assessment (SOFA) score is the most widely used tool for evaluating organ dysfunction.

This week, JAMA published the SOFA-2 score, a data-driven update that incorporates current organ support therapies and introduces new scoring thresholds. https://t.co/8C8omQv7w6

[Ross Prager @ross_prager]

(1/x) Andromeda-Shock 2 was just published in JAMA and is the most important septic shock trial in the past DECADE.

They found that phenotyped resuscitation improves the composite outcome of mortality, vital support, and hospital LOS.

Here's how you can apply this protocol to your practice 👇

[Adam Grippin @adam_grippin]

🚨Our new paper is out today in Nature! We show that SARS-CoV-2 mRNA vaccines can sensitize tumors to immune checkpoint blockade (ICI) — revealing that clinically available RNA vaccines may act as potent immune modulators. https://t.co/sH13agsz5c

[nature @Nature]

Nature research paper: SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade

https://t.co/AFQZS85y6f

[John A. Cuenca, MD @JohnCuencaMD]

Very happy to reconnect with many friends and mentors. #CHEST2025 @accpchest

[John A. Cuenca, MD @JohnCuencaMD]

Had a great time at #CHEST2025, tons of learning, inspiration, and fun! Grateful to @accpchest for an amazing meeting, and proud to represent @TigmerSA_IntMed with 3 posters this year.

[John A. Cuenca, MD @JohnCuencaMD]

What a privilege to have @Askins_Razor from @CritCareTime present a fantastic talk for @TigmerSA_IntMed Grand Rounds! #MedEd #MedTwitter

[ONCCC-R-NET @ONCCCRNET]

🚨Join us for the 3rd Virtual World Symposium of Oncologic Critical Care 🌏
Cutting-edge Science, Global collaboration, Expert insights on cancer & critical illness.
📆July 17-18! 🖥️ Virtual
🔗 REGISTER NOW: https://t.co/1yJuBdThAI

[John A. Cuenca, MD @JohnCuencaMD]

🎤 Honored to speak at the Third World Symposium of Oncologic Critical Care hosted by @MDAndersonNews & @ONCCCRNET

I’ll be presenting (in Spanish 🇪🇸) on immune checkpoint inhibitor-related respiratory failure, a growing challenge in #OncCrit.

#PCCM #Sepsis #Immunotherapy

[John A. Cuenca, MD @JohnCuencaMD]

That awesome moment when your mentee cites your work on her research. Proud of @paoyepezg growth and strong work in the oncologic critical care field. #ATS2025

[John A. Cuenca, MD @JohnCuencaMD]

Grateful for the opportunity to present 2 cases at #ATS2025—both cancer patients with resp failure and bilateral infiltrates:

❗️PJP and rhino-orbital mucormycosis
❗️Antibody-drug conjugate pneumonitis

Similar presentation, divergent etiologies.

Much research still needed🔬

[John A. Cuenca, MD @JohnCuencaMD]

We invite you to read our latest publication in @intensiva_med 📢

In this systematic review of septic shock RCTs, we found striking variability in how mortality timeframes are reported—making cross-trial comparisons challenging.

🔗 https://t.co/LF0MkQhggm
#Sepsis #MedTwitter

[SEMICYUC @semicyuc]

Últimos días para inscribirse en el Congreso Internacional de Oncología Crítica de la SEMICYUC.
Te esperamos en Sevilla el 27 y 28 de marzo.
Congreso presencial y online.
Más info.: https://t.co/WEBotLDFKx
#medicinaintensiva #intensivistas